Preliminary clinical data on the injection of MET CAR T cells into breast cancer tumors demonstrated favorable tolerability and induced necrosis, hemorrhage, and inflammatory cell infiltration within the tumor [219]. The gene discussed is MET; the disease is neoplasm.